A Phase III Trial of Carboplatin as Adjuvant Chemotherapy in Triple Negative Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01752686
Recruitment Status : Unknown
Verified December 2012 by Byeong Woo Park, Severance Hospital.
Recruitment status was:  Not yet recruiting
First Posted : December 19, 2012
Last Update Posted : December 25, 2012
Information provided by (Responsible Party):
Byeong Woo Park, Severance Hospital

No Study Results Posted on for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : March 2017
  Estimated Study Completion Date : March 2018